.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
UBS
Daiichi Sankyo
Mallinckrodt
Dow
Merck
Cantor Fitzgerald
Farmers Insurance
Citi
US Army

Generated: November 21, 2017

DrugPatentWatch Database Preview

VITRAVENE PRESERVATIVE FREE Drug Profile

« Back to Dashboard

What is the patent landscape for Vitravene Preservative Free, and what generic Vitravene Preservative Free alternatives are available?

Vitravene Preservative Free is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in VITRAVENE PRESERVATIVE FREE is fomivirsen sodium. Additional details are available on the fomivirsen sodium profile page.

Summary for VITRAVENE PRESERVATIVE FREE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
VITRAVENE PRESERVATIVE FREE
fomivirsen sodium
INJECTABLE;INJECTION020961-001Aug 26, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VITRAVENE PRESERVATIVE FREE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis
VITRAVENE PRESERVATIVE FREE
fomivirsen sodium
INJECTABLE;INJECTION020961-001Aug 26, 1998► Subscribe► Subscribe
Novartis
VITRAVENE PRESERVATIVE FREE
fomivirsen sodium
INJECTABLE;INJECTION020961-001Aug 26, 1998► Subscribe► Subscribe
Novartis
VITRAVENE PRESERVATIVE FREE
fomivirsen sodium
INJECTABLE;INJECTION020961-001Aug 26, 1998► Subscribe► Subscribe
Novartis
VITRAVENE PRESERVATIVE FREE
fomivirsen sodium
INJECTABLE;INJECTION020961-001Aug 26, 1998► Subscribe► Subscribe
Novartis
VITRAVENE PRESERVATIVE FREE
fomivirsen sodium
INJECTABLE;INJECTION020961-001Aug 26, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
AstraZeneca
Cipla
Teva
Daiichi Sankyo
Farmers Insurance
QuintilesIMS
Citi
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot